Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 BRAFV600E mutation and papillary thyroid cancer: chicken or egg?

Literature DB >> 22774213

BRAFV600E mutation and papillary thyroid cancer: chicken or egg?

Mingzhao Xing.

Abstract

Entities: Disease Mutation Species

Mesh：

Substances：

Year: 2012 PMID： 22774213 PMCID： PMC3387401 DOI： 10.1210/jc.2012-2201

Source DB: PubMed Journal: J Clin Endocrinol Metab ISSN： 0021-972X Impact factor: 5.958

× No keyword cloud information.

35 in total

1. The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.

Authors: Tae Hyuk Kim; Young Joo Park; Jung Ah Lim; Hwa Young Ahn; Eun Kyung Lee; You Jin Lee; Kyung Won Kim; Seo Kyung Hahn; Yeo Kyu Youn; Kwang Hyun Kim; Bo Youn Cho; Do Joon Park
Journal: Cancer Date: 2011-08-31 Impact factor: 6.860

2. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.

Authors: Edna T Kimura; Marina N Nikiforova; Zhaowen Zhu; Jeffrey A Knauf; Yuri E Nikiforov; James A Fagin
Journal: Cancer Res Date: 2003-04-01 Impact factor: 12.701

3. A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome.

Authors: Anna Guerra; Laura Fugazzola; Vincenzo Marotta; Massimo Cirillo; Stefania Rossi; Valentina Cirello; Irene Forno; Tania Moccia; Alfredo Budillon; Mario Vitale
Journal: J Clin Endocrinol Metab Date: 2012-04-16 Impact factor: 5.958

Review 4. Novel small molecule Raf kinase inhibitors for targeted cancer therapeutics.

Authors: Do-Hee Kim; Taebo Sim
Journal: Arch Pharm Res Date: 2012-05-03 Impact factor: 4.946

5. Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas.

Authors: Kristian Unger; Horst Zitzelsberger; Giuliana Salvatore; Massimo Santoro; Tatjana Bogdanova; Herbert Braselmann; Peter Kastner; Lyudmilla Zurnadzhy; Nikolay Tronko; Peter Hutzler; Gerry Thomas
Journal: J Clin Endocrinol Metab Date: 2004-09 Impact factor: 5.958

6. BRAF T1796A transversion mutation in various thyroid neoplasms.

Authors: M Xing; V Vasko; G Tallini; A Larin; Gujun Wu; R Udelsman; M D Ringel; P W Ladenson; D Sidransky
Journal: J Clin Endocrinol Metab Date: 2004-03 Impact factor: 5.958

7. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.

Authors: Paula Soares; Vítor Trovisco; Ana Sofia Rocha; Jorge Lima; Patrícia Castro; Ana Preto; Valdemar Máximo; Tiago Botelho; Raquel Seruca; Manuel Sobrinho-Simões
Journal: Oncogene Date: 2003-07-17 Impact factor: 9.867

8. BRAF mutation in papillary thyroid carcinoma.

Authors: Yoram Cohen; Mingzhao Xing; Elizabeth Mambo; Zhongmin Guo; Guogun Wu; Barry Trink; Uziel Beller; William H Westra; Paul W Ladenson; David Sidransky
Journal: J Natl Cancer Inst Date: 2003-04-16 Impact factor: 13.506

9. Mutations of the BRAF gene in human cancer.

Authors: Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal: Nature Date: 2002-06-09 Impact factor: 49.962

10. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.

Authors: Xiulong Xu; Roderick M Quiros; Paolo Gattuso; Kenneth B Ain; Richard A Prinz
Journal: Cancer Res Date: 2003-08-01 Impact factor: 12.701

9 in total

1. BRAF^V600E Mutation: Has It a Role in Cervical Lymph Node Metastasis of Papillary Thyroid Cancer?

Authors: Neslihan Kurtulmus; Burak Ertas; Yesim Saglican; Hakan Kaya; Umit Ince; Mete Duren
Journal: Eur Thyroid J Date: 2016-08-20

2. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

Authors: Mingzhao Xing; Ali S Alzahrani; Kathryn A Carson; Young Kee Shong; Tae Yong Kim; David Viola; Rossella Elisei; Bela Bendlová; Linwah Yip; Caterina Mian; Federica Vianello; R Michael Tuttle; Eyal Robenshtok; James A Fagin; Efisio Puxeddu; Laura Fugazzola; Agnieszka Czarniecka; Barbara Jarzab; Christine J O'Neill; Mark S Sywak; Alfred K Lam; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Hirotaka Nakayama; Roderick Clifton-Bligh; Giovanni Tallini; Elizabeth H Holt; Vlasta Sýkorová
Journal: J Clin Oncol Date: 2014-10-20 Impact factor: 44.544

Review 3. Molecular pathogenesis and mechanisms of thyroid cancer.

Authors: Mingzhao Xing
Journal: Nat Rev Cancer Date: 2013-03 Impact factor: 60.716

Review 4. New insights into the diagnosis of nodular goiter.

Authors: Anhelli Syrenicz; Monika Koziołek; Andrzej Ciechanowicz; Anna Sieradzka; Agnieszka Bińczak-Kuleta; Miłosz Parczewski
Journal: Thyroid Res Date: 2014-06-17

5. Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data.

Authors: Young Jun Chai; Jin Wook Yi; Hyeon-Gun Jee; Young A Kim; Ju Han Kim; Mingzhao Xing; Kyu Eun Lee
Journal: PLoS One Date: 2016-07-13 Impact factor: 3.240